Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients

Background: Pancreatic adenocarcinoma has a poor prognosis, resulting in a <10% survival rate at 5 years. Modulated electro-hyperthermia (mEHT) has been increasingly used for pancreatic cancer palliative care and therapy. Objective: To monitor the efficacy and safety of mEHT for the treatment of...

Full description

Bibliographic Details
Main Authors: Giammaria Fiorentini MD, Donatella Sarti PhD, Virginia Casadei MD, Carlo Milandri MD, Patrizia Dentico MD, Andrea Mambrini MD, Roberto Nani MD, Caterina Fiorentini MD, Stefano Guadagni MD
Format: Article
Language:English
Published: SAGE Publishing 2019-09-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/1534735419878505

Similar Items

Similar Items